Search Results

Clecell, Inc. commercializes the core 3D bioprinting technology developed by a Harvard Medical School team for over a decade. Clecell manufactures 3D human tissues for regenerative and precision medicine, and develops a clinical simulation platform based on these technologies.

GenesisTissue Inc. is a 3D bioprinting tissue company that designs and manufactures personalized regenerative tissue implants for humans

KeratOPrinter is an EU-funded research project dedicated to developing cutting-edge bioprinting solutions for corneal transplantation. By combining expertise from multiple disciplines, the project aims to produce a scalable, clinically viable solution to address the global challenge of corneal blindness.

We develop and implement innovative technological solutions based on biomaterials for the pharmaceutical, medical, and cosmetics industries. We specialize in chitosan and microcrystalline chitosan. We cooperate with scientists who have studied chitosan and its processing technologies in detail for many years.

Ronawk's Bio-Block Universe accelerates time to result by removing subculture, increasing biological yield by allowing cells to produce microenvironments as they would in the body, and creating an expandable environment without adding extensive time, labor, or costs. The impact is an increase in cell and biological opportunities while maintaining cell and tissue viability, key characteristics, and secretion of therapeutic biologics while lowering contamination risk.

We are a biodesign studio combining methods of microbiology and computational design technologies with expertise in 3D printed and robotically fabricated biomaterials. Our work sets out to uncover and highlight the beauty, intelligence, and complexity of microbial life for design systems. Our aim is to make products that reduce natural resources extraction and consumption, promoting long-term environmental health.

We are a biotechnology company that provides advanced solutions for medical research, drug discovery and regenerative medicine by integrating cutting-edge 3D bioprinting technology, biology expertise and a deep understanding of market needs, positioning us as a valuable asset for healthcare and biotech industries

LambdaVision is designing and developing an innovative, protein-based artificial retina that utilizes a light-activated protein, bacteriorhodopsin, to restore functional sight to those who would otherwise be blind due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). No cure exists for these diseases, and currently available treatments only slow their progression. There is a significant unmet need for the development of a treatment that restores meaningful vision to those affected. Through the development of an artificial retina, LambdaVision hopes to one day help patients regain vision so that they can complete everyday tasks with independence.

Founded in 2020, Balena is a material science company, developing advanced, compostable, recyclable, and bio-based thermoplastic materials. Balena is on a mission to create a circular model for durable consumer goods products and solve one of the industry's biggest challenges: the product's end-of-life, while reducing the dependency on fossil fuels.

Trestle Biotherapeutics, Inc. is a pre-clinical stage company developing bioengineered therapies for patients living with end stage renal disease. Once implanted, these bioengineered stem cell-derived tissues will get patients off dialysis, delay their need for transplantation, and one day become replacement organs.

Lattice Medical is a biomedical start-up that was launched in October 2017 Patented 3D technology developed with CHU Lille-France that allows adipose tissue to naturally regenerate